CURRENT NEWS

• 23.04.2019
  Asembia Introduces Managed Network for Retail Pharmacies
• 23.04.2019
  PATH and MMV Launch 5-Year Global Initiative to Support Elimination of Relapsing Malaria
• 23.04.2019
  Novartis’ Case for Innovative Gene Therapy for Spinal Muscular Atrophy
• 23.04.2019
  Marinomed’s Phase III Budesolv Trial Meets Endpoint
• 23.04.2019
  UPDATE -- AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
• 23.04.2019
  STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer
• 23.04.2019
  Rapid Medical Raises $20 Million in New Funding to Support Clinical and Commercialization of First-In-Class Stroke Treatment Products
• 23.04.2019
  ApiFix Completes Financing to Prepare for Commercial Efforts in the United States
• 23.04.2019
  HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China
• 23.04.2019
  First Varian Halcyon Treatments in Kenya Begin at Nairobi West Hospital
• 23.04.2019
  Futility Analysis Leads to Another CGRP Setback for Teva
• 23.04.2019
  US Patent Office Grants Charpentier/Doudna Key CRISPR Patent
• 23.04.2019
  Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for Hematological Malignancies
• 23.04.2019
  Microbot Medical Strengthens Global IP Portfolio With Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System
• 23.04.2019
  Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse Is Fully Planted; Reporting Year End Financials May 1st
• 23.04.2019
  Orphazyme’s Phase II/III Trial in Sporadic Inclusion Body Myositis Fully Enrolled
• 23.04.2019
  HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem Treatment for Acute Respiratory Distress Syndrome
• 23.04.2019
  Joseph J. Frendo Joins Caris Life Sciences as Chief Operations Officer
• 23.04.2019
  BAROnova Announces FDA Approval of the TransPyloric Shuttle (TPS) Device
• 23.04.2019
  Mallinckrodt Lupus Phase 4 Clinical Study for Acthar Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-To-Manage Population

Records per page:

Page

Total: 38022 records.